• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC CREATININE Back to Search Results
Catalog Number 03L81-22
Device Problems High Test Results (2457); Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/24/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is completed.
 
Event Description
The account generated a false elevated architect creatinine of 4.46 mg/dl on patient sample id (b)(6) that repeated 4.11 and 0.66 mg/dl.No specific patient information was provided.No impact to patient management was reported.
 
Event Description
Through the product quality investigation it was discovered that the architect creatinine of 4.46 and 4.11 mg/dl are the correct results and 0.66 mg/dl result is a false depressed result.Initially the patient generated architect creatinine of 4.46, 4.11 mg/dl but the results were questioned.The patient was tested again with architect creatinine of 0.66 mg/dl.Through troubleshooting, it was determined that the architect creatinine of 0.66 mg/dl was a false depressed result and the architect creatinine of 4.46, 4.11 mg/dl were the correct results.No impact to patient management was reported.
 
Manufacturer Narrative
Section b5.Additional information provided.Section d.4 and h.4: no expiration date or device manufacture date is available since the reagent lot is unknown.Section h.6 device code updated.Reaction graphs for the low sample show a lower absorbance value indicating less of a color development reaction than the original sample.No reagent lot number was available; however, trending of the assay finds no atypical complaint trends.No non-conformances for creatinine list number 3l81 related to the current event were found.Field data on patient population median results are within expected ranges at the time of the event.A review of the product labeling concluded that the issue is sufficiently addressed.No customer returns were available for evaluation.No product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE
Type of Device
CREATININE
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key9073278
MDR Text Key159033943
Report Number1628664-2019-00615
Device Sequence Number1
Product Code CGX
UDI-Device Identifier00380740005979
UDI-Public00380740005979
Combination Product (y/n)N
PMA/PMN Number
K981799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03L81-22
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/26/2019
Initial Date FDA Received09/16/2019
Supplement Dates Manufacturer Received10/28/2019
Supplement Dates FDA Received11/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT C8000 LIST 01G06-11,; ARCHITECT C8000 LIST 01G06-11,; SERIAL (B)(6). ; SERIAL (B)(6).
-
-